Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | UTHR |
---|---|---|
09:32 ET | 5495 | 313.8301 |
09:34 ET | 1800 | 312.73 |
09:36 ET | 100 | 313.775 |
09:38 ET | 1400 | 315.46 |
09:39 ET | 200 | 315.46 |
09:43 ET | 1800 | 313.19 |
09:45 ET | 200 | 313.655 |
09:48 ET | 1300 | 314.3 |
09:52 ET | 400 | 313.61 |
09:54 ET | 200 | 314.395 |
09:57 ET | 300 | 314.4 |
09:59 ET | 1775 | 315.57 |
10:01 ET | 200 | 316.08 |
10:06 ET | 100 | 315.99 |
10:08 ET | 200 | 315.81 |
10:10 ET | 200 | 316.53 |
10:15 ET | 5311 | 315.81 |
10:17 ET | 100 | 316.03 |
10:19 ET | 300 | 316.095 |
10:21 ET | 1000 | 316 |
10:24 ET | 719 | 315.64 |
10:26 ET | 900 | 315.7 |
10:28 ET | 500 | 316 |
10:30 ET | 5204 | 316.53 |
10:32 ET | 2425 | 316.755 |
10:33 ET | 613 | 316.54 |
10:35 ET | 3391 | 316.51 |
10:37 ET | 1500 | 317.25 |
10:39 ET | 400 | 317.76 |
10:42 ET | 2137 | 317.579 |
10:44 ET | 150 | 317.835 |
10:50 ET | 1609 | 318.13 |
10:51 ET | 1642 | 318.33 |
10:53 ET | 400 | 318.42 |
10:57 ET | 2912 | 318.3 |
11:00 ET | 530 | 317.83 |
11:02 ET | 700 | 318.2 |
11:04 ET | 400 | 317.87 |
11:06 ET | 200 | 317.7 |
11:08 ET | 626 | 317.5 |
11:13 ET | 200 | 316.92 |
11:18 ET | 101 | 316.6 |
11:20 ET | 300 | 316.55 |
11:22 ET | 100 | 316.35 |
11:24 ET | 325 | 316.075 |
11:26 ET | 500 | 316.715 |
11:33 ET | 100 | 316.785 |
11:36 ET | 1275 | 316.23 |
11:40 ET | 206 | 316.47 |
11:42 ET | 604 | 316.035 |
11:44 ET | 400 | 316.27 |
11:45 ET | 550 | 316.33 |
11:49 ET | 100 | 316.65 |
11:51 ET | 100 | 316.81 |
11:56 ET | 1227 | 316.86 |
12:00 ET | 100 | 316.86 |
12:02 ET | 400 | 316.705 |
12:07 ET | 250 | 316.65 |
12:09 ET | 1486 | 316.095 |
12:12 ET | 1269 | 316.655 |
12:16 ET | 300 | 317 |
12:20 ET | 100 | 317.16 |
12:27 ET | 200 | 317.5 |
12:30 ET | 100 | 317.52 |
12:32 ET | 100 | 317.19 |
12:34 ET | 100 | 317.62 |
12:36 ET | 100 | 317.515 |
12:38 ET | 100 | 317.635 |
12:39 ET | 100 | 317.97 |
12:41 ET | 1167 | 317.59 |
12:43 ET | 200 | 317.34 |
12:45 ET | 837 | 317.33 |
12:48 ET | 252 | 317.18 |
12:50 ET | 400 | 316.585 |
12:52 ET | 200 | 316.92 |
12:54 ET | 100 | 317.13 |
12:57 ET | 100 | 317.145 |
12:59 ET | 100 | 317.15 |
01:08 ET | 300 | 317.54 |
01:10 ET | 603 | 317.76 |
01:12 ET | 100 | 317.77 |
01:14 ET | 893 | 317.54 |
01:19 ET | 101 | 317.54 |
01:24 ET | 700 | 317.41 |
01:26 ET | 100 | 317.33 |
01:28 ET | 300 | 317.525 |
01:32 ET | 500 | 317.825 |
01:33 ET | 500 | 317.89 |
01:37 ET | 100 | 317.78 |
01:42 ET | 400 | 317.98 |
01:44 ET | 100 | 317.985 |
01:46 ET | 216 | 318 |
01:48 ET | 2921 | 318.08 |
01:50 ET | 200 | 318.46 |
01:51 ET | 458 | 318.54 |
01:53 ET | 1971 | 318.08 |
01:55 ET | 100 | 318.21 |
02:08 ET | 100 | 318.05 |
02:09 ET | 200 | 318.05 |
02:13 ET | 100 | 318.24 |
02:15 ET | 200 | 318.11 |
02:18 ET | 300 | 318.49 |
02:20 ET | 100 | 318.78 |
02:22 ET | 1610 | 318.33 |
02:24 ET | 612 | 318.21 |
02:27 ET | 100 | 318.1 |
02:29 ET | 100 | 318.26 |
02:31 ET | 200 | 318.7 |
02:33 ET | 935 | 318.505 |
02:36 ET | 623 | 318.23 |
02:40 ET | 200 | 318.04 |
02:44 ET | 100 | 317.93 |
02:49 ET | 618 | 318.11 |
02:51 ET | 443 | 318.125 |
02:56 ET | 1150 | 318.02 |
03:00 ET | 300 | 318.05 |
03:05 ET | 100 | 318.34 |
03:07 ET | 953 | 318.275 |
03:09 ET | 526 | 317.865 |
03:12 ET | 300 | 317.92 |
03:14 ET | 100 | 317.7215 |
03:16 ET | 302 | 317.59 |
03:18 ET | 243 | 317.57 |
03:23 ET | 300 | 317.71 |
03:27 ET | 200 | 317.7624 |
03:32 ET | 1532 | 317.615 |
03:34 ET | 300 | 317.79 |
03:38 ET | 1422 | 317.45 |
03:39 ET | 200 | 317.31 |
03:41 ET | 300 | 317.195 |
03:43 ET | 500 | 317.38 |
03:45 ET | 200 | 317.34 |
03:48 ET | 1240 | 317.45 |
03:50 ET | 300 | 317.53 |
03:52 ET | 2467 | 316.94 |
03:54 ET | 334 | 316.585 |
03:56 ET | 3471 | 316.43 |
03:57 ET | 5866 | 317.08 |
03:59 ET | 6575 | 316.89 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
United Therapeutics Corp | 14.0B | 15.0x | +8.22% |
Biomarin Pharmaceutical Inc | 15.5B | 77.2x | --- |
Neurocrine Biosciences Inc | 14.0B | 39.1x | +62.04% |
Beigene Ltd | 16.2B | -19.1x | --- |
Medpace Holdings Inc | 12.5B | 41.3x | +35.10% |
Exact Sciences Corp | 8.2B | -34.1x | --- |
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $14.0B |
---|---|
Revenue (TTM) | $2.5B |
Shares Outstanding | 44.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.55 |
EPS | $21.13 |
Book Value | $127.23 |
P/E Ratio | 15.0x |
Price/Sales (TTM) | 5.6 |
Price/Cash Flow (TTM) | 12.6x |
Operating Margin | 50.31% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.